|
| 36455943 | One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment. | Journal of Rheumatology | 2023 |
| 36370181 | F-sodium fluoride PET-CT visualizes both axial and peripheral new bone formation in psoriatic arthritis patients. | European Journal of Nuclear Medicine and Molecular Imaging | 2023 |
| 36278846 | Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence-Based Data Analyses of a National Multicenter Prospective Registry. | Arthritis Care and Research | 2023 |
| 35543102 | Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial. | Scandinavian Journal of Rheumatology | 2023 |
| 36319019 | Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors. | Journal of Rheumatology | 2023 |
| 37975166 | Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis; results from the EuroSpA Research Collaboration Network. | | 2023 |
| 38071514 | Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature. | | 2023 |
| 36508028 | [F]Fluoride PET provides distinct information on disease activity in ankylosing spondylitis as compared to MRI and conventional radiography. | | 2023 |
| 36810788 | Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data. | | 2023 |
| 36463635 | Corrigendum to 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration' [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081]. | Semin Arthritis Rheum | 2023 |
| 35323903 | The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis. | Rheumatology | 2022 |
| 36109666 | Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis. | Nature reviews. Rheumatology | 2022 |
| 36178585 | Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review. | Rheumatology and Therapy | 2022 |
| 35962246 | The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study. | Clinical Rheumatology | 2022 |
| 35383121 | Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study. | RMD Open | 2022 |
| 35429281 | Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials. | Advances in Therapy | 2022 |
| 35940824 | Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force. | RMD Open | 2022 |
| 36333501 | Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. | Nat Genet | 2022 |
| 35985172 | Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration. | Semin Arthritis Rheum | 2022 |
| 34219406 | Progression From Subclinical Inflammation to Overt Spondyloarthritis in First-Degree Relatives of Patients in Association With HLA-B27: The Pre-Spondyloarthritis Cohort. | Arthritis Care and Research | 2022 |
| 33460531 | Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries. | Arthritis Care and Research | 2022 |
| 34726125 | Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study. | Scandinavian Journal of Rheumatology | 2022 |
| 35169057 | High Prevalence of Previously Undiagnosed Axial Spondyloarthritis in Patients Referred With Anterior Uveitis and Chronic Back Pain: The SpEYE Study. | Journal of Rheumatology | 2022 |
| 35219889 | Does gender modify outcome in rheumatic diseases? | Joint Bone Spine | 2022 |
| 35156061 | COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases. | Lancet Rheumatology, The | 2022 |
| 34768587 | The Prevalence of Cardiac Diseases in a Contemporary Large Cohort of Dutch Elderly Ankylosing Spondylitis Patients-The CARDAS Study. | Journal of Clinical Medicine | 2021 |
| 34180159 | Reply. | Arthritis and Rheumatology | 2021 |
| 33854572 | Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study. | Therapeutic Advances in Musculoskeletal Disease | 2021 |
| 32749781 | Multidisciplinary management of auto-immune ocular diseases in adult patients by ophthalmologists and rheumatologists. | Acta Ophthalmologica | 2021 |
| 33278588 | Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels. | Joint Bone Spine | 2021 |
| 33277982 | Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six-Month Results of a Placebo-Controlled Trial. | Arthritis and Rheumatology | 2021 |
| 32776224 | The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis. | Rheumatology International | 2021 |
| 34618347 | A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis. | Rheumatology and Therapy | 2021 |
| 33053194 | Sex and gender differences in axial spondyloarthritis: myths and truths. | Rheumatology | 2020 |
| 32371433 | The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW. | RMD Open | 2020 |
| 31960053 | Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14Â 868 patients with spondyloarthritis. | Rheumatology | 2020 |
| 32007935 | The Ankylosing Spondylitis Performance Index: Reliability and Feasibility of an Objective Test for Physical Functioning. | Journal of Rheumatology | 2020 |
| 32109577 | Patients with axial spondyloarthritis report significant differences between men and women and high impact of the disease: Large websurvey analysis. | Joint Bone Spine | 2020 |
| 31665497 | Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. | Rheumatology | 2020 |
| 32340708 | Axial Spondyloarthritis in the Era of Precision Medicine. | Rheumatic Disease Clinics of North America | 2020 |
| 32453036 | Sex differences in disease activity and efficacy of treatment in spondyloarthritis: is body composition the cause? | Current Opinion in Rheumatology | 2020 |
| 31916108 | Presence of active MRI lesions in patients suspected of non-radiographic axial spondyloarthritis with high disease activity and chance at conversion after a 6-month follow-up period. | Clinical Rheumatology | 2020 |
| 32950963 | Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration. | RMD Open | 2020 |
| 30943139 | Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic data. | Clinical and Experimental Rheumatology | 2019 |
| 30353386 | First-degree relatives of axial spondyloarthritis patients of the pre-SpA cohort would consider using medication in a preventive setting. | Clinical Rheumatology | 2019 |
| 30385705 | Reduced Occurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis Treated with Golimumab - The GO-EASY Study. | Journal of Rheumatology | 2019 |
| 30690799 | Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis. | Journal of Bone and Mineral Research | 2019 |
| 31422357 | MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group. | Annals of the Rheumatic Diseases | 2019 |
| 31431486 | Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. | Annals of the Rheumatic Diseases | 2019 |
| 31433400 | Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort. | Rheumatology Advances in Practice | 2018 |